Journal profile · ENDOCRINOLOGY & METABOLISM
Endokrynologia Polska
ISSN 0423-104X · eISSN 2299-8306 · Via Medica · POLAND · Bimonthly · Founded 1950
Endokrynologia Polska: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.2; fully open access; APC charged, amount not published; median 57 days to acceptance (96 articles, last 24 months); community-reported acceptance: easy; 93 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Endokrynologia Polska is published by Via Medica and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Thyroid Cancer Diagnosis and Treatment, Thyroid Disorders and Treatments and Pituitary Gland Disorders and Treatments, together about 31.6% of its articles. Its main subfields are Endocrinology, Diabetes and Metabolism. (generated from OpenAlex topic counts and CAS ranking data)
Endokrynologia Polska (Endokrynol Pol) is an official journal of the Polish Society of Endocrinology (Polskie Towarzystwo Endokrynologiczne, PTE). This bimonthly, open access and peer-reviewed international journal publishes papers in English on clinical and experimental endocrinology, diabetology and metabolic diseases. The following types of articles may be submitted for publication: original research papers, reviews, reviews (postgraduate education), short communications, clinical vignette and letters to the editor (readers’ forum). The journal also publishes guidelines, expert opinions, editorials and conference materials (congressional papers and abstracts).
From the journal's Aims & Scope
Research area (LetPub): ENDOCRINOLOGY & METABOLISM
Editor-in-chief Dariusz KajdaniukPublisher website
Editorial board by country: none in mainland China; most named Poland 62, United States 5, Italy 3, United Kingdom 2, Hungary 2 (77 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Thyroid Cancer Diagnosis and TreatmentMedicine11.8%
- Thyroid Disorders and TreatmentsMedicine10.2%
- Pituitary Gland Disorders and TreatmentsMedicine9.7%
- Neuroendocrine Tumor Research AdvancesMedicine6.4%
- Thyroid and Parathyroid SurgeryMedicine5.4%
- Parathyroid Disorders and TreatmentsMedicine5.1%
- Adrenal and Paraganglionic TumorsMedicine5.1%
- Growth Hormone and Insulin-like Growth FactorsMedicine5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Endocrinology & Metabolism | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Endocrinology & Metabolism | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Endocrinology & Metabolism | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceMEDLINEEmbaseCASPublisher website
Other: Google Scholar, EBSCO, ProQuest, CNKI, OCLC, Crossref, ICI Journal Master List, SJR (Scimago Journal & Country Rank), Arianta, Biochemistry and Biophysics Citation Index, CNKI (China National Knowledge Index), Free Medical Journals (Geneva Foundation), Medical Journals Links, Polish Scientific Bibliography/Polindex, Polska Bibliografia Naukowa (PBN), Polish Medical Library (GBL), ROAD (Directory of Open Access Scholarly Resources), Urlichs' Periodicals Directory, WorldCat (OCLC)
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.2LetPub ·
- CiteScore 2026-06
- 2.9LetPub ·
- SJR 2026-06
- 0.5LetPub ·
- SNIP 2026-06
- 0.61LetPub ·
- h-index
- 24LetPub ·
- h-index
- 39OpenAlex ·
- i10-index
- 333OpenAlex ·
- 2-year mean citedness
- 1.43OpenAlex ·
- Self-citation rate
- 9.1%LetPub ·
- Share of gold OA articles
- 99.51%LetPub ·
Volume
- Articles per year
- 70LetPub ·
Articles by year OpenAlex count · 1,162 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 67 | 67 | 6 |
| 2025 | 93 | 93 | 122 |
| 2024 | 94 | 94 | 234 |
| 2023 | 89 | 89 | 416 |
| 2022 | 100 | 100 | 695 |
| 2021 | 103 | 103 | 787 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
57 daysMedian, submission to acceptance · P25–P75 39 days – 85 days
- Acceptance to online
- median 69 days (57 articles)
- Submission to online
- median 137 days
- Sample
- 96 articles with submission and acceptance dates (158 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Acceptance rate (publisher)
- 25%Publisher website ·
- Submission to first decision
- 3 daysPublisher website ·
- Submission to publication (journal-reported)
- about 20 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 700 | No | CC BY-NC-ND | |
| OpenAlex | EUR 500 | — | — | |
| LetPub | EUR 615 | No | — | |
| Publisher website | EUR 800 / EUR 500 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Keywords
- 3–6
- Manuscript length
- ≤ 3,500 words
- Reference style
- Vancouver
- Cover letter
- Required
Article types accepted9, with length limits
- clinical practice guidelinesThe Journal publishes the following types of peer-reviewed articles: — original research papers, — review articles, — clinical practice guidelines, — expert rec…Length not stated
- clinical vignettesThe Journal publishes the following types of peer-reviewed articles: — original research papers, — review articles, — clinical practice guidelines, — expert rec…Length not stated
- expert recommendations/position statementsThe Journal publishes the following types of peer-reviewed articles: — original research papers, — review articles, — clinical practice guidelines, — expert rec…Length not stated
- original research paperd supplementary files: same as with the original Research papers, however with a limit of no more than 6000 words. EP Editors prefer papers based upon a systema…main text ≤ 6,000 words
- original research papersThe Journal publishes the following types of peer-reviewed articles: — original research papers, — review articles, — clinical practice guidelines, — expert rec…Length not stated
- revieworiginal research papers — 3500 words, review — 6000 words, short communication — 1000 words (these limits are exclusimain text ≤ 6,000 words
- review articlesThe Journal publishes the following types of peer-reviewed articles: — original research papers, — review articles, — clinical practice guidelines, — expert rec…Length not stated
- short communicationpers — 3500 words, review — 6000 words, short communication — 1000 words (these limits are exclusive of abstracts, tables, illustratmain text ≤ 1,000 words
- short communicationsThe Journal publishes the following types of peer-reviewed articles: — original research papers, — review articles, — clinical practice guidelines, — expert rec…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Plagiarism
- AI use
AI use disclosure required. Model summary
Authors are required to disclose any use of artificial intelligence (AI) tools, including generative models, at any stage of manuscript preparation, data analysis, or the development of accompanying materials.
Source ↗Publisher website ·- Authorship Authorship
ORCID iD requested. Model summary
All individuals who have significantly contributed to the manuscript are considered co-authors. All the co-authors are obliged to indicate their contribution to the publication (conception, design, methods, investigations, analysis of data, writing of the manuscript, etc.). One co-author may indicate more than one type of contribution and the same type of contribution may be indicated by more th…
Source ↗Publisher website ·- Conflicts of interest
Conflict of interest disclosure for authors. Model summary
At the time of manuscript submission, authors of research papers are obliged to disclose any financial arrangements they might have with the company whose product played an important role in the research or with the company manufacturing a competitor product.
Source ↗Publisher website ·- Data availability
Data availability statement required. Model summary
Authors should indicate whether the source data underlying the submitted manuscript are available to other researchers.
Source ↗Publisher website ·- Publication ethics
Declaration of Helsinki endorsement for human subjects research. Model summary
The Editors of the Journal endorse the principles laid down in the Declaration of Helsinki and expect all the research involving human subjects to have been conducted in accordance with these principles.
Source ↗Publisher website ·- License & copyright Copyright Notice
No publication elsewhere without written consent. Model summary
Completion of the online submission form electronically is tantamount to automatically and free-of-charge transferring of the copyright for publishing and distribution of the submitted material (in all known now and developed in the future forms and fields of exploitation) to the copyright holder, i.e. Polish Society of Endocrinology, under condition that those materials are accepted for publicati…
Source ↗Publisher website ·- Open access Open Access Policy
Articles published on-line in the Journal are available in open access immediately after publication and are published under Creative Common Attribution-Non Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercia…
Source ↗Publisher website ·- Peer review Peer review process
Acceptance requires favourable opinions of Editors, reviewers, and Editor-in-Chief. Model summary
Electronically submitted manuscripts are first checked by the Journal’s editors for completeness and compliance with the house style requirements outlined below. Manuscripts that are incomplete and/or do not comply with the Journal’s house style are rejected without further review. Manuscripts that are complete and comply with the Journal’s house style are reviewed by the Journal’s Editors and, i…
Source ↗Publisher website ·- Plagiarism
Originality declaration; not published or submitted elsewhere. Model summary
By submitting the manuscript electronically, along with illustrations and tables, the authors declare that it has not been published before or submitted to the editorial board of any other journal (except for abstracts of up to 350 words).
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Via Medica
- Country or region
- POLAND
- Language
- Polish, English
- Frequency
- Bimonthly
- Founded
- 1950
- ISSN
- 0423-104X
- Electronic ISSN
- 2299-8306
- Society / sponsor
- Polish Society of Endocrinology
- Latest issue on the website
- Volume 77, Issue 4 (2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Endokrynologia Polska
What CAS zone is Endokrynologia Polska in?
In the 2025 upgraded edition of the CAS Journal Ranking, Endokrynologia Polska is in Zone 4 of Medicine, and in Zone 4 of the minor category Endocrinology & Metabolism. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Endokrynologia Polska?
The latest impact factor listed by LetPub is 2.2; CiteScore 2.9, h-index 39.
How long does peer review take at Endokrynologia Polska?
Based on the dates recorded on 96 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 57 days (interquartile range 39–85 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”; the journal's website gives an acceptance rate of 25%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Endokrynologia Polska?
According to the journal's author guidelines: Keywords: 3–6; Manuscript length: ≤ 3,500 words; Reference style: Vancouver; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Endokrynologia Polska based?
Of the 77 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Poland (62), United States (5) and Italy (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Endokrynologia Polska?
According to LetPub and DOAJ records, Endokrynologia Polska is indexed in SCIE, Scopus and DOAJ. The journal's website also lists Web of Science, MEDLINE, Embase and CAS; that list has not been checked against each database.
Is Endokrynologia Polska open access, and what is the APC?
Endokrynologia Polska is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .